Head-to-head · WeighScore
FitRx vs GetRelief Rx
The verdict
FitRx takes it — 66/100 to 58.6/100.
FitRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | FitRx | GetRelief Rx |
|---|---|---|
| WeighScore | 66/100 | 58.6/100 |
| Grade | C | C |
| Scorecard rank | #211 | #365 |
| Semaglutide | $151/mo (quarterly plan, compounded) | $269/mo (9 mg dose, compounded oral) |
| Tirzepatide | Not disclosed | $179/mo (16 mg dose, compounded oral) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #211 · C
Strengths
- Insurance coordination for brand-name GLP-1s — as low as $25/mo
- All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
- LegitScript certified
- All 50 states + DC coverage
- Compounded semaglutide from $151/mo quarterly for uninsured patients
Where it loses points
- Insurance coordination may not work for all plans
- Broader platform (birth control, mental health, hair loss, ED, skincare, primary care)
- Compounded option is semaglutide only — no compounded tirzepatide
Graded #365 · C
Strengths
- Compounded semaglutide and tirzepatide priced publicly — no login required to see costs
- BBB accredited with an A rating (March 2026)
- Free online assessment with no upfront consultation fee
Where it loses points
- Sublingual drops only — no injectable; this delivery method wasn't studied in the STEP/SURMOUNT trials
- Still sells compounded tirzepatide after the FDA ended compounding enforcement discretion in 2025
- No LegitScript, PCAB, or NABP pharmacy certifications found
- Prescriber credentials listed only as 'licensed clinicians' with no detail on degree type
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.